{"id":"https://openalex.org/W2789433883","doi":"https://doi.org/10.1016/j.ejca.2018.02.016","title":"A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)","display_name":"A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)","publication_year":2018,"publication_date":"2018-03-20","ids":{"openalex":"https://openalex.org/W2789433883","doi":"https://doi.org/10.1016/j.ejca.2018.02.016","mag":"2789433883","pmid":"https://pubmed.ncbi.nlm.nih.gov/29547834"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejca.2018.02.016","doi":"https://doi.org/10.1016/j.ejca.2018.02.016","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejca.2018.02.016","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065433718","display_name":"Henrik Lindman","orcid":"https://orcid.org/0000-0002-5871-268X","observed_orcids":["https://orcid.org/0000-0002-5871-268X"]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"H. Lindman","raw_affiliation_strings":["Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden. Electronic address: henrik.lindman@igp.uu.se","Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden. Electronic address: henrik.lindman@igp.uu.se","institution_ids":["https://openalex.org/I1342360035"]},{"raw_affiliation_string":"Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101542399","display_name":"Michael Andersson","orcid":"https://orcid.org/0000-0003-4440-4800","observed_orcids":["https://orcid.org/0000-0003-4440-4800"]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"M. Andersson","raw_affiliation_strings":["Department of Oncology, Rigshospitalet, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Rigshospitalet, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Ahlgren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142144","display_name":"G\u00e4vle Hospital","ror":"https://ror.org/04esjnq02","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210142144"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J. Ahlgren","raw_affiliation_strings":["Department of Oncology, G\u00e4vle Hospital, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, G\u00e4vle Hospital, Sweden","institution_ids":["https://openalex.org/I4210142144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015859540","display_name":"Eva Balslev","orcid":"https://orcid.org/0000-0003-4187-4508","observed_orcids":["https://orcid.org/0000-0003-4187-4508"]},"institutions":[{"id":"https://openalex.org/I2801827564","display_name":"Herlev Hospital","ror":"https://ror.org/00wys9y90","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"E. Balslev","raw_affiliation_strings":["Department of Oncology, Herlev Hospital, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Herlev Hospital, Denmark","institution_ids":["https://openalex.org/I2801827564"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047819372","display_name":"\u00c1sger\u00f0ur Sverrisd\u00f3ttir","orcid":"https://orcid.org/0000-0003-3632-8166","observed_orcids":["https://orcid.org/0000-0003-3632-8166"]},"institutions":[{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"A. Sverrisdottir","raw_affiliation_strings":["Department of Oncology, S\u00f6dersjukhuset, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, S\u00f6dersjukhuset, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210094988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001454220","display_name":"Stig B. Holmberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.B. Holmberg","raw_affiliation_strings":["Department of Surgery, M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, M\u00f6lndal, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109996829","display_name":"Nils\u2010Olof Bengtsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099621","display_name":"University Hospital of Ume\u00e5","ror":"https://ror.org/012k96e85","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210099621"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"N.O. Bengtsson","raw_affiliation_strings":["Department of Oncology, Ume\u00e5 University Hospital, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Ume\u00e5 University Hospital, Sweden","institution_ids":["https://openalex.org/I4210099621"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110664668","display_name":"Erik Hugger Jacobsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"E.H. Jacobsen","raw_affiliation_strings":["Department of Oncology, Vejle Hospital, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Vejle Hospital, Denmark","institution_ids":["https://openalex.org/I4210091196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042847019","display_name":"Anders Bonde Jensen","orcid":"https://orcid.org/0000-0002-6319-563X","observed_orcids":["https://orcid.org/0000-0002-6319-563X"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"A.B. Jensen","raw_affiliation_strings":["Department of Oncology, Aarhus University Hospital, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Aarhus University Hospital, Denmark","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Hansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107386","display_name":"V\u00e4stmanlands sjukhus V\u00e4ster\u00e5s","ror":"https://ror.org/01qh83x04","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210107386"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J. Hansen","raw_affiliation_strings":["Department of Oncology, V\u00e4ster\u00e5s Hospital, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, V\u00e4ster\u00e5s Hospital, Sweden","institution_ids":["https://openalex.org/I4210107386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076740464","display_name":"Malgorzata K. Tuxen","orcid":"https://orcid.org/0009-0003-2466-0767","observed_orcids":["https://orcid.org/0009-0003-2466-0767"]},"institutions":[{"id":"https://openalex.org/I2801827564","display_name":"Herlev Hospital","ror":"https://ror.org/00wys9y90","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"M.K. Tuxen","raw_affiliation_strings":["Department of Oncology, Herlev Hospital, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Herlev Hospital, Denmark","institution_ids":["https://openalex.org/I2801827564"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006055583","display_name":"Lena Malmberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119959","display_name":"Karlstad Central Hospital","ror":"https://ror.org/02kwcpg86","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210119959"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"L. Malmberg","raw_affiliation_strings":["Department of Oncology, Karlstad Hospital, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Karlstad Hospital, Sweden","institution_ids":["https://openalex.org/I4210119959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110538601","display_name":"Kenneth Villman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129463","display_name":"\u00d6rebro University Hospital","ror":"https://ror.org/02m62qy71","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210129463"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"K. Villman","raw_affiliation_strings":["Department of Oncology, \u00d6rebro University Hospital, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, \u00d6rebro University Hospital, Sweden","institution_ids":["https://openalex.org/I4210129463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107849817","display_name":"H. Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"H. Anderson","raw_affiliation_strings":["Division of Cancer Epidemiology, Department of Clinical Sciences, Lund University, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Epidemiology, Department of Clinical Sciences, Lund University, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034630560","display_name":"Bent Ejlertsen","orcid":"https://orcid.org/0000-0001-8761-714X","observed_orcids":["https://orcid.org/0000-0001-8761-714X"]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"B. Ejlertsen","raw_affiliation_strings":["Department of Oncology, Rigshospitalet, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Rigshospitalet, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071571360","display_name":"Jonas C. S. Bergh","orcid":"https://orcid.org/0000-0001-5526-1847","observed_orcids":["https://orcid.org/0000-0001-5526-1847"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J. Bergh","raw_affiliation_strings":["Radiumhemmet, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiumhemmet, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062149739","display_name":"CARL P. BLOMQVIST","orcid":"https://orcid.org/0000-0003-3041-1938","observed_orcids":["https://orcid.org/0000-0003-3041-1938"]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"C. Blomqvist","raw_affiliation_strings":["Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5065433718"],"corresponding_institution_ids":["https://openalex.org/I1342360035"],"apc_list":{"value":4270,"currency":"USD","value_usd":4270},"apc_paid":null,"fwci":0.2266,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.42174301,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"94","issue":null,"first_page":"79","last_page":"86"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.8759999871253967},{"id":"https://openalex.org/keywords/fec-regimen","display_name":"FEC regimen","score":0.6669999957084656},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8840000033378601},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":1.0},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8460000157356262},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.824999988079071},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7459999918937683},{"id":"https://openalex.org/keywords/body-surface-area-dosing","display_name":"body surface area dosing","score":0.8330000042915344},{"id":"https://openalex.org/keywords/distant-disease-free-survival","display_name":"distant disease-free survival","score":0.9890000224113464},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.972001314163208},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.8119235634803772},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7400641441345215},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.7217753529548645},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6544971466064453},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6323335766792297},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.585218071937561},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5535488724708557},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5521763563156128},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3141222596168518}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.ejca.2018.02.016","doi":"https://doi.org/10.1016/j.ejca.2018.02.016","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejca.2018.02.016","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:29547834","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29547834","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer (Oxford, England : 1990)","raw_type":"Journal Article"},{"id":"pmh:oai:lup.lub.lu.se:8bd2a596-d3ff-40c8-a87e-372d08c86459","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/8bd2a596-d3ff-40c8-a87e-372d08c86459","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 0959-8049","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:publications/c4440cf8-165e-46f5-9068-0b46e692184e","doi":null,"is_oa":false,"landing_page_url":"https://pure.au.dk/portal/en/publications/c4440cf8-165e-46f5-9068-0b46e692184e","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Swedish Breast Cancer Group (SweBCG), the Danish Breast Cancer Group (DBCG) and the Scandinavian Breast Cancer Group (SBG) 2018, 'A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)', European Journal of Cancer, vol. 94, pp. 79-86. https://doi.org/10.1016/j.ejca.2018.02.016","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.hirsla.lsh.is:2336/620584","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2336/620584","pdf_url":null,"source":{"id":"https://openalex.org/S4306401083","display_name":"Hirsla (Landsp\u00edtali University Hospital)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210106610","host_organization_name":"National University Hospital of Iceland","host_organization_lineage":["https://openalex.org/I4210106610"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321491","display_name":"Cancerfonden","ror":"https://ror.org/0527jb766"},{"id":"https://openalex.org/F4320321957","display_name":"Herlev Hospital","ror":"https://ror.org/00wys9y90"},{"id":"https://openalex.org/F4320322315","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1701849548","https://openalex.org/W1927722732","https://openalex.org/W1973258451","https://openalex.org/W2031871398","https://openalex.org/W2043458021","https://openalex.org/W2053543045","https://openalex.org/W2066514716","https://openalex.org/W2084654918","https://openalex.org/W2110400978","https://openalex.org/W2124387763","https://openalex.org/W2129727563","https://openalex.org/W2133714238","https://openalex.org/W2135800076","https://openalex.org/W2136802843","https://openalex.org/W2137028370","https://openalex.org/W2138764684","https://openalex.org/W2146878374","https://openalex.org/W2167779518","https://openalex.org/W2169388316","https://openalex.org/W2214665719","https://openalex.org/W2521150987","https://openalex.org/W2550262309","https://openalex.org/W4234837271"],"related_works":["https://openalex.org/W2310228730","https://openalex.org/W2138764684","https://openalex.org/W2944761881","https://openalex.org/W2108951978","https://openalex.org/W310618382","https://openalex.org/W283562313","https://openalex.org/W642318819","https://openalex.org/W2138991012","https://openalex.org/W2101231158","https://openalex.org/W2146878374"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-03-29T00:00:00"}